Moderna Capitalizes on Stock Jump With $2 Billion Note Offering
Moderna Inc. plans to raise $2 billion from selling notes that can be exchanged for shares, which it will use to invest in its cancer vaccine business and to repay debt.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.